Dec 19 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX :
* TELIX PHARMACEUTICALS- GRANTED PERMISSION TO SUBMIT FINAL STAGE APPLICATION BY 11 JAN 2019 FOR PHASE I/II STUDY OF 89ZR-GIRENTUXIMAB IN JAPAN BY PMDA
Dec 19 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX :
* TELIX PHARMACEUTICALS- GRANTED PERMISSION TO SUBMIT FINAL STAGE APPLICATION BY 11 JAN 2019 FOR PHASE I/II STUDY OF 89ZR-GIRENTUXIMAB IN JAPAN BY PMDA